Results 131 to 131 of about 552 (131)

Results of a 12-Week Open-Label, Non-Interventional Study of the Efficacy and Safety of Olokizumab Therapy in Patients with Rheumatoid Arthritis after Switching from Anti-B-Cell Therapy during the SARS-CoV-2 Pandemic

Doklady Biochemistry and Biophysics
E A Letyagina, Maxim Korolev
exaly